RE: It's not in parallel22 Nov 2023 21:41
Totally agree Energy, if it's working not only the FDA but all cancer patients will want this available as a treatment ASAP.
Who on earth would want standard doxorubicin pumped into them with AVA6000 around.
The logistics of bringing AVA6000 to market quickly is way beyond Avactaβs capability, I can only hope that they already in talks with big pharma.
GLA